Divamics is an AI- and dynamics-based biotech company specializing in drug discovery, with a primary focus on autoimmune and metabolic diseases.

Using our cutting-edge AI-driven molecular dynamic platform, we develop innovative pipelines targeting these areas. We are actively seeking collaboration opportunities for licensing and co-development, aiming to accelerate drug discovery, optimize clinical strategies, and improve success rates. Our platform significantly reduces trial-and-error costs in preclinical development, and we are committed to advancing transformative treatments for patients.